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Abstract
Purpose To examine caregivers’ health-related quality of
life (HRQoL) and well-being during the first 3 years after
their family member’s Alzheimer’s disease (AD) diagnosis
and assessed the relationship between caregivers’ HRQoL,
well-being, and the severity of AD. Further, to compare of
caregivers’ HRQoL to general population.
Methods Longitudinal design (36 months) after AD diag-
nosis of 236 caregiver–patient dyads. Linear regression was
used to assess age- and gender-adjusted association between
repeated measurements of caregivers’ HRQoL and the severity
of AD. For comparison with general population, the National
Health 2011 Health Examination Survey data was utilized.
Results Caregivers had significantly lower HRQoL than
age- and gender-standardized counterparts. Severity of AD
was significantly (p\ 0.05) associated with the mobility
and depression dimensions of caregiver’s HRQoL but not
with the total HRQoL index score.
Conclusions Caregivers’ HRQoL seems to deteriorate
earlier than previously noted. The severity of AD has not
that great impact on caregiver’s HRQoL as assumed.
Keywords Family caregivers  Alzheimer’s disease 
Health-related quality of life  15D  Psychological distress
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QIC Quasi-AIC
VAS Visual analog scale
Introduction
Family caregiving has become an established practice in
caring for people with Alzheimer’s disease (AD). Family
caregivers’ health-related quality of life (HRQoL) and
well-being have been recognized as major elements in the
success of home care [1–5] as well as predictors of insti-
tutionalization in persons with AD [1, 6].
HRQoL is a broad concept that is affected in complex
ways by a person’s physical health, psychological state,
level of independence, social relationships, and relation-
ship with salient features of his or her environment [7].
Cross-sectional studies have established an association
between decreasing HRQoL and increasing caregiver bur-
den [4, 8, 9], including decreased ability to maintain
interests other than caregiving [10].
Family caregivers’ HRQoL is affected by their subjec-
tive experiences, such as a feeling of burnout [3], depres-
sive symptoms [11], sense of hope [12], and patient-related
factors [8, 11]. The severity of the patient’s neuropsychi-
atric symptoms has an impact on caregivers’ HRQoL [8,
13]. An increase in the patient’s dependence level [9] and
more time-consuming daily caregiving [8, 9] were associ-
ated with lower HRQoL for caregivers. Further studies
examining the association between patients’ cognitive
status and caregivers’ HRQoL have yielded conflicting
results. Markowitz et al. [8] found a significant relationship
between caregivers’ mental functioning aspects of HRQoL
and caregivers’ ratings of patients’ cognitive, behavioral,
and depressive symptoms. Despite recognition of the effect
of these patient-related factors on family caregivers’
HRQoL, little evaluation of the relationship of caregiver
HRQoL to AD severity has been previously conducted.
Therefore, we aimed to (1) characterize caregivers’
HRQoL and well-being during the first 3 years of follow-
up after their family member’s AD diagnosis, (2) perform
comparisons of caregivers with an age- and gender-stan-
dardized sample of the general population to assess the
impact of caregiving on caregivers’ HRQoL, and (3) assess
the relationship between the HRQoL and well-being of the
caregivers and the AD severity of the patients.
Methods
Study population
The present study analyzed data collected as part of the
ALSOVA study. The design of the ALSOVA study has
been reported previously [14, 15]. Briefly, AD patients and
their family caregivers (n = 236) were recruited from three
memory polyclinics between 2002 and 2006, soon after a
family member had received an AD diagnosis (on average
within 5 months after the diagnosis). Caregivers had daily
contact with their family member, and patients had a
baseline of very mild (Clinical Dementia Rating, CDR 0.5)
or mild (CDR 1) AD at diagnosis. All the family members
with AD were home dwelling. Data on age, education,
living arrangements, household composition were collected
at the baseline and during the annual follow-up visits.
AD diagnosis confirmation and assessment of progression
A family member presenting with neurodegenerative disorder
was examined, and AD was diagnosed by a geriatrician or
neurologist. The National Institute of Neurological and Com-
municative Disorders and Stroke and Alzheimer’s Disease and
Related Disorders Association (NINCDS-ADRDA) [16] and
the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) [17] criteria were used. A study
neurologist confirmed the clinical AD diagnosis. All patients
underwent diagnostic evaluation, including brain imaging (CT
or MRI), and were advised to initiate AD-targeted drug therapy
at the time of diagnosis or at the baseline visit.
The clinical parameters used in this study were mea-
sured at baseline and annually over the 3-year follow-up
period by a trained study nurse or a psychologist. The
severity of AD was evaluated using Clinical Dementia
Rating Scale Sum of Boxes scores (CDR-SOB), range 0–18
[18]. Cognitive impairment was assessed using the mini-
mental state examination (MMSE), range 0–30 [19], and
activities of daily living were assessed using the Alzhei-
mer’s Disease Cooperative Study Activities of Daily Liv-
ing scale (ADCS-ADL), range 0–78 [20, 21].
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Health-related quality of life
Caregivers’ HRQoL and well-being were measured using
the 15D instrument [22] and visual analog scale (VAS),
respectively. The 15D is a generic, standardized prefer-
ence-based utility measure that has both profile and single
index score properties [22]. The 15D assesses 15 dimen-
sions: mobility, vision, hearing, breathing, sleeping, eating,
speech, excretion, usual activities, mental function, dis-
comfort and symptoms, depression, distress, vitality, and
sexual activity. These dimensions can be presented as
profiles or as a single 15D index score, which is obtained
by weighting all 15 dimensions with population-based
preference weights that are assigned based on an applica-
tion of the multi-attribute utility theory [23]. Both profile
and index scores vary between 0 and 1, where 0 represents
death and 1 represents perfect HRQoL. Recently, it has
been shown that a difference of 0.015 in the 15D index
score can be considered a minimal clinically important
difference (in the sense that subjects can feel the differ-
ence) [24]. A directly elicited, vertical VAS scored from 0
(death) to 100 (full health) [25] was used as a measurement
of well-being.
Statistical analysis
Descriptive statistics were used to summarize data as per-
centages, means, standard deviation (SD), and 95 % con-
fidence intervals (95 % CIs) as appropriate. To study the
impact of caregiving on HRQoL, the AD caregivers were
compared with a representative sample of the Finnish
general population with corresponding 15D measurements
obtained from the National Health 2011 Health Examina-
tion Survey (n = 7964). [26]. Survey participants, who
were in the age range of caregivers (i.e., 35–84 years of
age), were selected from the population sample
(n = 4458). To enable statistical comparison, the popula-
tion sample was weighted to reflect the age and gender
distribution of the caregivers. Two-tailed t test was used to
evaluate the significance of differences between the groups.
To study the age- and gender-adjusted relationship
between the HRQoL (15D and VAS) and the severity of
AD (CDR-SOB), we utilized repeated-measures linear
regression using a generalized estimating equation (GEE)
model. GEE models take into account the between-subject
differences and within-subject correlations, such as those
within longitudinal repeated-measures data. The GEE
models were specified using a Gaussian distribution,
identity link function, and unstructured correlation matrix.
Goodness of fit of the GEE models was examined using
Akaike information criteria (AIC) and residual plots (for
goodness of fit of the mean models), as well as quasi-AIC
(QIC) (for correlation structures in GEE models).
All analyses were conducted using IBM SPSS software
for Windows, version 19.0, and STATA, version 9.2. The
threshold used to define statistical significance was
p\ 0.05.
Ethical considerations
The ethics committee of Kuopio University Hospital
reviewed the ethical issues involved in this study (64/00)
and approved the ALSOVA project. The study was
approved by the Finnish Supervisory Authority for Welfare
and Health and the Finnish Ministry of Social Affairs and
Health.
The study was carried out in accordance with the Hel-
sinki Declaration [27]. Willing participants were recruited
on a voluntary basis. Both written and oral information
about the study were given before participants were asked
to give written consent. A consent form was signed by both
the caregiver and the AD patient. The caregiver also pro-
vided proxy consent on behalf of the individual with AD.
An initial visit was arranged soon after the diagnosis for
those who gave consent. The voluntary nature of partici-
pation and the confidentiality of the data collected were
emphasized at every study visit.
Results
Sample characteristics
Descriptive characteristics of the study sample are pre-
sented in Table 1. In brief, the mean age of caregivers was
65.7 years at the baseline and 67 % were female. The
majority of caregivers (75 %) lived in the same household
with the patient. The mean cohabitation time was 33 years
(SD 1.7). A total of 108 (46 %,) caregivers did not com-
plete all three follow-up visits. Six (3 %) family caregivers
and 27 (11 %) persons with AD died during the follow-up
period. Analysis showed that the caregivers who completed
the full three-year follow-up reported significantly milder
depressive symptoms (BDI 8.42 vs. 10.5, p = .014), better
well-being at baseline (VAS 77.1 vs 72.4, p = .03) but no
significant difference on baseline 15D index. Also, better
patient performance in activities of daily living was shown
than the caregiver–patient dyads who were lost to follow-
up (ADCS-ADL 66.3 vs. 62.4, p = .001). In addition,
patients’ with full follow-up had numerically slightly better
CDR-SOB (3.98 vs. 4.30, p = .10).
Caregivers’ quality of life and well-being
The mean 15D index score of the caregivers stayed rel-
atively stable with no statistically significant mean change
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over the observed period. The average change from
baseline was -0.008 (95 % CI -0.019–0.004) over
3 years of follow-up. Caregivers’ well-being (VAS) was
at baseline 77.3 (95 % CI 74.8–79.9). It deteriorated
significantly (p\ 0.001) to 73.9 (95 % CI 70.8–77.05) at
the year three. The mean 15D score for the general
population was 0.898 (SD 0.09) at the baseline and fol-
low-up points 0.898 (SD 0.09), 0.987 (0.09), and, 0.892
(0.09), respectively.
Caregivers’ quality of life compared
to that of the general population
The caregivers’ mean 15D index score was already sig-
nificantly poorer than the corresponding 15D index score of
age- and gender-standardized general population at the
time of the baseline measurement (mean difference -0.018
(95 % CI -0.005–0.029); p\ 0.01). This significant dif-
ference between caregivers and their age- and gender-s-
tandardized counterparts remained throughout the entire
follow-up period (Fig. 1).
Family caregivers had significantly lower HRQoL than
the general age- and gender-standardized population on
seven of fifteen HRQoL dimensions: vision, breathing,
usual activities, depression, distress, vitality, and sexual
activity (Fig. 2).
Table 1 Demographic data for
caregivers (n = 236) and AD
patients (n = 236)
Characteristics Baseline (n = 236) Year 1 (n = 198) Year 2 (n = 168) Year 3 (n = 131)
Caregivers
Gender
Male 33.5 % (79) 31.8 % (63) 33.3 % (56) 36.7 % (48)
Age 65.7 (11.9) 66.7 (11.8) 67.4 (11.9) 68.6 (11.8)
(35–84) (36–85) (38–86) (41–87)
5D index score 0.882 (0.087) 0.880 (0.085) 0.873 (0.092) 0.878 (0.093)
VAS score 75.0 (16.6) 74.8 (16.6) 72.6 (18.7) 71.4 (18.0)
Patients
Gender
Male 48.7 % (115) 47.0 % (93) 45.8 % (77) 43.5 % (57)
Age 75.6 (6.5) 76.5 (6.8) 77.5 (6.9) 78.5 (6.4)
ADCS-ADL 64.5 (8.9) 58.0 (12.7) 51.2 (15.9) 46.0 (18.4)
MMSE 21.5 (3.4) 19.3 (4.3) 17.5 (5.5) 16.4 (5.1)*
CDR-SOB 4.1 (1.5) 5.6 (2.3) 7.1 (3.0) 8.3 (3.4)**
CDR
Very mild 54.2 % (128) 32.3 % (64) 16.1 % (27) 6.2 % (8)**
Mild 45.8 % (108) 56.6 % (112) 57.7 % (97) 58.1 % (75)**
Moderate 0 % (0) 11.1 % (22) 25.0 % (42) 31.0 % (40)**
Severe 0 % (0) 0 % (0) 1.2 % (2) 4.7 % (6)**
Values are presented as means (SD = standard deviation) or frequency (%, n/N)
15D Health-related quality of life (scale 0–1), VAS visual analog scale (scale 0–100), ADCS-ADL activities
of daily living (scale 0–78), MMSE mini-mental state examination (scale 0–30), CDR-SOB Clinical
Dementia Rating Sum of Boxes (scale 0–18), CDR Clinical Dementia Rating (scale 0–3)
* MMSE n=125; ** CDR-SOB, CDR n= 129
Difference in 15D index
-0,06 -0,04 -0,02 0,00 0,02
Baseline
Year 1
Year 2
Year 3
Fig. 1 Mean difference with 95 % CI in the 15D index score
between the caregivers and an age- and gender-standardized sample
of the general population in different time points of measurement. A
vertical dash line at zero indicates no difference between the groups,
and negative numbers indicate poorer HRQoL for caregivers. A
dashed line indicates no difference between groups
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Association between caregivers’ QoL, well-being,
and the severity of AD
Over the three-year follow-up period, the overall mean
(95 % CI) annual increase in CDR-SOB was 1.65
(1.47–1.78) points per year (p\ 0.001). Although there
was a significant association between the caregivers’ age-
and gender-adjusted well-being (VAS) and the AD sever-
ity, the association between caregivers’ overall HRQoL
(15D index) and patients’ disease severity was not signif-
icant (Fig. 3). The age- and gender-adjusted VAS score
decreased by 0.558 (p = 0.019) for every one-unit increase
in CDR-SOB scores. Within all 15 dimensions of HRQoL,
only the mobility and depression dimensions were signifi-
cantly associated with the severity of AD (CDR-SOB)
(Fig. 4). The age- and gender-adjusted mobility and
depression dimension score decreased by 0.004 (p\ 0.01)
and 0.003 (p = 0.033), respectively, for every one-unit
increase in CDR-SOB scores.
Discussion
This is the first comparison of family caregivers’ 15D
scores (HRQoL) to those of a sample of age- and gender-
standardized general population in a longitudinal study
setting we are aware of. The results indicate that family
caregivers already have a significantly lower quality of life
than their age- and gender-standardized counterparts by the
time of AD diagnosis. Even though the overall HRQoL
remained relatively constant during 36-month follow-up
period, family caregivers scored lower on several dimen-
sions of HRQoL. Patients’ disease severity was correlated
with caregivers’ subjective well-being, but not with the
overall HRQoL index score or the majority of the dimen-
sional scores. The observed small change in the mean 15D
score can be considered to be a minimally clinically
important difference [24]; however, it was not statistically
significant in the analyses presented here. The severity of
AD may not have as great an impact on the caregivers’
HRQoL as was previously concluded based on cross-sec-
tional studies. [3, 8, 11]. However, the lack of significant
effect over the course of the follow-up may be explained by
the observation that caregivers’ mean HRQoL had already
significantly decreased by the time of AD diagnosis, thus
reducing the magnitude of further changes after the
diagnosis.
Our data suggest that caregivers’ HRQOL deteriorates
earlier than expected during the gradual decline in AD
patients’ cognition. Even though our patient sample was at
a mild or very mild stage of AD at the baseline measure-
ment, negative effects on caregiver HRQoL had already
occurred. This could be explained by the observation that
the caregiving process begins very early, even before an
early diagnosis of AD, [28] or the deterioration of HRQoL
is rapid during the early days of caregiving. Further
investigation of the caregiving process is warranted to
determine when it starts and what characteristics define
caregivers who will experience the greatest negative
impact on their health and HRQoL. It should be noted that
during the observed period a degree of accommodations
might have occurred. However, we recognize possible
selection bias during the follow-up. Contradictory findings
exist in the literature regarding the impact on caregivers. In
some reports, early caregiving was associated with
increased burden [29, 30] and loss of intimacy [30] among
caregivers for patients with mild cognitive impairment
(MCI). However, in other studies, MCI caregivers were
shown to experience normal levels of depressive symp-
toms, HRQoL, and sense of mastery [31, 32] Thus, it is
difficult to predict when or whether certain caregivers will
start to suffer from psychosocial deficits causing weaken-
ing HRQoL, and this is an important issue for future
research.
Although no previous longitudinal studies exist regard-
ing dementia caregivers’ HRQoL compared to an age- and
gender-standardized population, our findings are supported
by cross-sectional studies finding poorer HRQoL [33] and
higher frequency of problems on each of the HRQoL
dimensions compared with the general population [9] using
different HRQoL scales.
In our study, family caregivers show differences from
the general age- and gender- standardized population on
seven of the HRQoL dimensions: vision, breathing, usual
activities, depression, distress, and sexual activity. The
physical components of HRQoL are strongly related to age
and somatic conditions [34]. Furthermore, it is well docu-
mented that prolonged caregiving with dementia patients
constitutes a risk to physical health and that caregivers are
more likely to report their health to be fair or poor than
non-caregivers [35]. Interestingly, no significant differ-
ences with respect to sleep were observed between care-
givers and the general population during 36 months of
follow-up. Sleep disturbances have previously been
reported to relate to depressive symptoms and they may
negatively affect QoL and health outcomes [5, 36]. Two-
thirds of caregivers have reported sleep disturbances, but
correlation with the severity of the patients’ dementia or
cognitive function was not observed [37].
Caregivers’ relatively poor perceived HRQoL, particu-
larly with respect to mental health and distress dimensions,
has been shown previously using several instruments in
different cultures [4, 38–40]. Our earlier cross-sectional
results showed that a complex relationship exists between
HRQoL and depressive symptoms, distress, and health-
protective factors such as a sense of coherence [41]. The
Qual Life Res (2016) 25:687–697 691
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Difference in MOVE dimension
-0,06 -0,04 -0,02 0,00 0,02
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Year 1
Year 2
Year 3
Difference in VISION dimension
-0,08 -0,06 -0,04 -0,02 0,00 0,02
Baseline
Year 1
Year 2
Year 3
Difference in HEAR dimension
-0,06 -0,04 -0,02 0,00 0,02
Baseline
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Year 2
Year 3
Difference in BREATH dimension
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Baseline
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Difference in SLEEP dimension
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Difference in EAT dimension
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Difference in SPEECH dimension
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Difference in EXCRET dimension
-0,06 -0,04 -0,02 0,00 0,02 0,04 0,06
Baseline
Year 1
Year 2
Year 3
Difference in UACT dimension
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Difference in MENTAL dimension
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Difference in DISCO dimension
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Difference in DEPR dimension
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Difference in DISTR dimension
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Difference in VITAL dimension
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Difference in SEX dimension
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Baseline
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impact of AD on intimacy and the sexual side of the
relationship is evident in comparison with an age- and
gender-standardized population. Our results corroborate
previous findings that dementia reduces the importance of
sexual relationship in couples [42, 43].
Our results demonstrate the impact of the disease
severity (CDR-SOB) on the family caregivers’ HRQoL on
both mood- and burden-related dimensions, but not with
respect to the overall HRQoL score. This finding agrees
with that of a large cross-sectional study on HRQoL [44]
where the AD stage did not significantly associate with the
caregivers’ HRQoL score. However, other studies report
that low patient cognition, neuropsychiatric symptoms, and
caregiver burden are associated with effects on caregivers’
HRQoL [9–11], and some studies also report association
with early institutionalization [1, 6].
A main strength of our study is the longitudinal design,
starting at the time of early AD diagnosis, which is rare
among HRQoL studies in caregiving settings. This study
also features a comparison between our study population
with an age- and gender-standardized control population.
In the evaluation of AD severity, we used a global and
continuous measure CDR-SOB that does not appear to
have the pitfalls of MMSE, in which previous reports
suggest may inaccurately reflect the total impact, progres-
sion, and consequences of AD, and produce volatile esti-
mates [45, 48]. When compared to the categorical version,
CDR global rating, the continuous CDR-SOB provides a
more detailed and sophisticated measure of disease sever-
ity, and is better suited for disease progression evaluation
[46–48].
The fairly high dropout rate (46 %) is a potential limi-
tation of this study; however, it is comparable with that
seen in other caregiver studies having a similar design [48,
49]. Further limitation may be the possible selection bias of
the primary recruiting process as the most burdened care-
givers might refuse to participate to the follow-up study. As
a subjective assessment, VAS includes all of the aspects
that caregivers find to have impact on their well-being;
however, there are limitations with the VAS, including
possible bias in measurement due to multiple better and
worse states presenting at the same time, or due to
respondents’ reluctance to choose values on either end of
the scale [50]. In this sample, the significant better VAS
score within those caregivers’ with full follow-up data is a
source of weakness in this study. Despite these limitations,
the VAS proved to detect the deterioration of well-being
within our sample.
The quality of AD patients’ home care and their overall
well-being rests greatly on their caregivers’ ability to
maintain a good quality of life. Caregivers HRQoL and
subjective sense of well-being are fundamental to preserve.
Along with postponing the patients’ institutionalization,
bFig. 2 Age- and gender-standardized measurements of individual
health-related quality of life (15D) dimensions with 95 % CI. Family
caregivers exhibited significantly lower HRQoL on seven of fifteen
HRQoL dimensions (vision, breathing, usual activities, depression,
distress, vitality, and sexual activity) when compared with the general
age- and gender-standardized population. Vertical dash lines at zero
indicate no difference between the groups. A dashed line indicates no
difference between groups
CDR-SOB
0 2 4 6 8 10 12 14 16 18
W
el
l-b
ei
ng
 (V
A
S
)
50
60
70
80
90
100
b-coefficient for linear trend: -0.558 (p=0.02)
CDR-SOB
0 2 4 6 8 10 12 14 16 18
15
D
 In
de
x
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: -0.001 (p=0.08)
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Qual Life Res (2016) 25:687–697 693
123
CDR-SOB
M
ob
ili
ty
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: -0.004 (p=0.008)
CDR-SOB
V
is
io
n
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: 0.000 (p=0.940)
CDR-SOB
H
ea
rin
g
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: 0.000 (p=0.594)
CDR-SOB
B
re
at
hi
ng
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: 0.000 (p=0.968)
CDR-SOB
S
le
ep
in
g
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: -0.002 (p=0.242)
CDR-SOB
E
at
in
g
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: 0.000 (p=0.797)
CDR-SOB
S
pe
ec
h
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: -0.002 (p=0.162)
CDR-SOB
E
xc
re
tio
n
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: 0.000 (p=0.931)
CDR-SOB
U
su
al
 a
ct
iv
iti
es
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: -0.003 (p=0.217)
CDR-SOB
M
en
ta
l f
un
ct
io
n
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: 0.002 (p=0.267)
CDR-SOB
D
is
co
m
fo
rt 
an
d 
sy
m
pt
om
s
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: -0.003 (p=0.267)
CDR-SOB
D
ep
re
ss
io
n
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: -0.003 (p=0.033)
CDR-SOB
D
is
tre
ss
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: 0.001 (p=0.497)
CDR-SOB
V
ita
lit
y
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: -0.003 (p=0.063)
CDR-SOB
S
ex
ua
l a
ct
iv
ity
0,5
0,6
0,7
0,8
0,9
1,0
b-coefficient for linear trend: -0.003 (p=0.369)
0 2 4 6 8 10 12 14 16 18 0 2 4 6 8 10 12 14 16 18 0 2 4 6 8 10 12 14 16 18
0 2 4 6 8 10 12 14 16 18
0 2 4 6 8 10 12 14 16 18
0 2 4 6 8 10 12 14 16 18
0 2 4 6 8 10 12 14 16 180 2 4 6 8 10 12 14 16 180 2 4 6 8 10 12 14 16 18
0 2 4 6 8 10 12 14 16 18
0 2 4 6 8 10 12 14 16 18
0 2 4 6 8 10 12 14 16 18 0 2 4 6 8 10 12 14 16 18
0 2 4 6 8 10 12 14 16 18
0 2 4 6 8 10 12 14 16 18
694 Qual Life Res (2016) 25:687–697
123
taking care of the caregivers’ own physical and psy-
chosocial health has to be a priority of health care provi-
ders. Caregivers’ depressive symptoms may turn out to be
strong factors impacting HRQoL and well-being during the
caregiving years.
Identification of the most vulnerable caregivers at the
time of diagnosis can facilitate proactive, tailored support
to promote the well-being of both patient and caregiver.
Family caregivers live in close contact with their care
recipients, and this should be considered in the develop-
ment of these programs. Effective family-oriented support
and need-based intervention programs to address care-
givers’ psychosocial resources and needs should be
developed and provided along with more traditional care
that focuses on the patient’s condition.
Concluding, caregivers had significantly lower HRQoL
than age- and gender-standardized counterparts and it
remains considerable stable over caregiving period. The
severity of AD (very mild, mild–moderate or severe AD)
has not that great impact on caregiver’s HRQoL as previ-
ously assumed.
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